DSM-5 mixed specifier for manic episodes: Evaluating the effect of depressive features on severity and treatment outcome using asenapine clinical trial data

Journal of Affective Disorders - Tập 150 - Trang 378-383 - 2013
R.S. McIntyre1, M. Tohen2, M. Berk3,4,5,6, J. Zhao7, E. Weiller8
1Mood Disorders Psychopharmacology Unit, University Health Network, University of Toronto, ON, Canada M5T 2S8
2University of New Mexico, Health Science Center, Department of Psychiatry, Albuquerque, NM, USA
3Deakin University School of Medicine, VIC, Australia
4The University of Melbourne, Department of Psychiatry, Parkville, VIC, Australia;
5Orygen Youth Health Research Centre, Parkville, VIC, Australia
6Florey Institute for Neuroscience and Mental Health, Parkville, VIC, Australia
7Merck, Whitehouse Station, NJ 08889, USA
8H Lundbeck A/S, Corporate Medical Affairs, Valby, Copenhagen, Denmark

Tài liệu tham khảo

Azorin, 2013, Effect of asenapine on manic and depressive symptoms in bipolar I patients with mixed episodes: results from post hoc analyses, Journal of Affective Disorders, 145, 62, 10.1016/j.jad.2012.07.013 Cipriani, 2011, Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis, The Lancet, 378, 1306, 10.1016/S0140-6736(11)60873-8 Guy, 1976, Clinical global impressions, 217 Kay, 1987, The Positive and Negative Syndrome Scale (PANSS) for schizophrenia, Schizophrenia Bulletin, 13, 261, 10.1093/schbul/13.2.261 Kupfer, D.J., Angst, J., Berk, M., Dickerson, F., Frangou, S., Frank, E., Goldstein, B.I., Harvey, A., Laghrissi-Thode, F., Leboyer, M., Ostacher, M.J., Sibille, E., Strakowski, S.M., Suppes, T., Tohen, M., Yolken, R.H., Young, L.T., Zarate, C.A., 2011. Advances in bipolar disorder. In: Selected Sessions from the 2011 International Conference on Bipolar Disorder. Annals of the New York Academy of Sciences. 1242, 1–25. McElroy, 1992, Clinical and research implications of the diagnosis of dysphoric mania or hypomania, American Journal of Psychiatry, 149, 1633, 10.1176/ajp.149.12.1633 McElroy, 2008, Understanding the complexity of bipolar mixed episodes, Journal of Clinical Psychiatry, 69, e06, 10.4088/JCP.0208e06 McIntyre, 2009, A 3-week, randomized, placebo-controlled trial of asenapine in the treatment of acute mania in bipolar mania and mixed states, Bipolar Disorders., 11, 673, 10.1111/j.1399-5618.2009.00748.x McIntyre, 2010, Asenapine in the treatment of acute mania in bipolar I disorder: a randomized, double-blind, placebo-controlled trial, Journal of Affective Disorders, 122, 27, 10.1016/j.jad.2009.12.028 Montgomery, 1979, Depressive symptoms in acute schizophrenia, Progress in Neuro-psychopharmacology, 3, 429, 10.1016/0364-7722(79)90058-4 Suppes, 2005, Mixed hypomania in 908 patients with bipolar disorder evaluated prospectively in the Stanley Foundation Bipolar Treatment Network: a sex-specific phenomenon, Archives of General Psychiatry., 62, 1089, 10.1001/archpsyc.62.10.1089 Swann, 2013, Multivariate analysis of bipolar mania: retrospectively assessed structure of bipolar I manic andmixed episodes in randomized clinical trial participants, Journal of Affective Disorders, 144, 59, 10.1016/j.jad.2012.05.061 Szegedi, 2011, Effects of asenapine in patients with bipolar I disorder experiencing acute manic or mixed episodes. A post-hoc analysis of two 3-week clinical trials, BMC Psychiatry, 11, 101, 10.1186/1471-244X-11-101 Tohen, 1990, Outcome in mania. A 4-year prospective follow-up of 75 patients utilizing survival analysis, Archives of General Psychiatry, 47, 1106, 10.1001/archpsyc.1990.01810240026005 Yildiz, 2011, Efficacy of antimanic treatments: meta-analysis of randomized, controlled trials, Neuropsychopharmacology, 36, 375, 10.1038/npp.2010.192 Young, 1978, A rating scale for mania: reliability, validity and sensitivity, British Journal of Psychiatry, 133, 429, 10.1192/bjp.133.5.429